Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens. [electronic resource]
Producer: 20120918Description: 547-53 p. digitalISSN:- 1559-131X
- Adolescent
- Adult
- Aged
- Anthracyclines -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Bridged-Ring Compounds -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Methotrexate -- therapeutic use
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Prognosis
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retrospective Studies
- Survival Rate
- Taxoids -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.